Home
Alnylam Pharmaceuticals ALNY paid Splitoak Strategies $50K for lobbying in Q4 2023 · Medicare
Trade details
- Type
- Lobbying report
- Amount
- $50,000
- Quarter
- Q4 2023
- Client
- Alnylam Pharmaceuticals
- Reported
- 24/01/19
Up 0.0% from last quarter
What else happened in Alnylam Pharmaceuticals around then
Filed or reported within 30 days of the trade day · 23/12/01~24/01/30Alnylam Pharmaceuticals's other lobbying reports
- Alnylam Pharmaceuticals
LobbyingAlnylam Pharmaceuticals
LobbyingAlnylam Pharmaceuticals
ALNY
$450K
$450K
Reported 07/20
for Q2
- Alnylam Pharmaceuticals
LobbyingAlnylam Pharmaceuticals
LobbyingAlnylam Pharmaceuticals
ALNY
$60K
$60K
Reported 07/20
for Q2
- Alnylam Pharmaceuticals
LobbyingAlnylam Pharmaceuticals
LobbyingAlnylam Pharmaceuticals
ALNY
$60K
$60K
Reported 07/20
for Q2
- Alnylam Pharmaceuticals
LobbyingAlnylam Pharmaceuticals
LobbyingAlnylam Pharmaceuticals
ALNY
$60K
$60K
Reported 07/19
for Q2
- Alnylam Pharmaceuticals
LobbyingAlnylam Pharmaceuticals
LobbyingAlnylam Pharmaceuticals
ALNY
$30K
$30K
Reported 07/16
for Q2